Evidence map›Paper›PMID 40711183›Full record

ArticleNanomaterials (Basel, Switzerland)2025

Xiaoyu Chang, Huina Xiao, Mingsong Li, Yongshuai Jing, Kaiyan Zheng, Beibei Hu, Yuguang Zheng, Lanfang Wu

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoyu ChangCollege of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
Huina XiaoCollege of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
Mingsong LiCollege of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.
Yongshuai JingCollege of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.ORCID 0000-0002-9362-4554
Kaiyan ZhengCollege of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
Beibei HuCollege of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.
Yuguang ZhengCollege of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
Lanfang WuCollege of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.

Funding

the earmarked fund for Hebei Agriculture Research System (HARS) HBCT2023080201, HBCT2023080205the Hebei Natural Science Foundation H2024423098
6 · The paper itself

Abstract

Green-synthesized metal nanoparticles show promise in nanomedicine and material engineering. In this study, the polysaccharide of

Indexed as

antibacterial activitycharacterizationimmunomodulatory activitynanoparticlesprocess optimizationZingiber officinale

Identifiers

PMID40711183
PMCPMC12300654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.